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Abstract 
Purpose: To investigate the protective effects of ligustrazine on oxidative stress-induced 
atherosclerosis.  
Methods: The indicators related to oxidative stress were determined using commercially available 
assay kits. MTT assay was used to assess the survival rate of human umbilical vein endothelial cells 
(HUVECs). HUVECs apoptosis was analyzed using fluorescence staining and flow cytometry. mRNA 
expression level and activity of caspases 3, 8, and 9 were determined via quantitative real-time 
polymerase chain reaction (PCR) and caspase 3, 8, and 9 assay kits.  
Results: Ligustrazine concentration of < 80 µmol/L had negligible inhibitory effect on HUVECs viability 
and protected HUVECs against oxygen stress damage by regulating the indicators related to oxidative 
stress. Flow cytometry results show that ligustrazine ameliorated H2O2-induced apoptosis, while the 
proportion of cells that stepped into early apoptosis and late apoptosis or necrosis were 52.7 and 0.6 %, 
respectively, in the H2O2 group, and 38.2 and 1.3 %, respectively, in the ligustrazine group. In addition, 
ligustrazine attenuated the up-regulation of caspase 3, 8, and 9 mRNA expression levels and activity.  
Conclusion: Ligustrazine can protect HUVECs against H2O2-induced injuries by regulating the 
indicators related to oxidative stress and suppressing the overexpression of caspases 3, 8, and 9. The 
protective mechanism of ligustrazine on H2O2-induced injury in HUVECs may be a caspase-dependent 
anti-apoptotic mechanism which provide important information for treating and preventing oxidative 
stress-induced atherosclerosis. 
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Atherosclerosis (AS) is the primary cause of 
cardiovascular and cerebrovascular diseases [1]. 
Substantial evidence indicates that oxidative 
stress contributes to the progression of AS [2]. 
Oxidative stress can result in endothelial 
damage [3]. Injury to endothelial cells is the 
initiating factor of AS [4]. 
 
Cells usually have three model systems for 
oxidative stress: extracellular sources of 
superoxide anion (O2-), hydroxyl radical (H2O2), 
and normobaric hyperoxia (elevated ambient 
oxygen) [5]. Among the three, H2O2 has been 
extensively used to induce endothelial cell-injury 
models in vitro because it can easily penetrate 
the plasma membrane and does not play a role 
in initiating lipid pre-oxidation and oxidizing DNA 
and amino acids [4].  
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Recently, many studies have suggested that 
natural bioactive compounds from plants can 
protect endothelial cells against oxidative 
damage [6]. Ligustrazine (tetramethy-pyrazine) is 
the major active ingredient extracted from 
Ligusticum chuanxiong and is widely applied in 
the treatment of vascular diseases in China [7]. 
Previous studies have reported that ligustrazine 
can effectively scavenge cytotoxic oxygen free 
radicals that can alleviate hepatic and kidney cell 
damage [8,9]. However, the potential mechanism 
of ligustrazine involved in AS was still obscure. 
Therefore, in the present study, the H2O2-
induced oxidative stress model was established 
using human umbilical vein endothelial cells 
(HUVECs) to explore the anti-oxidative effects of 
ligustrazine on oxidative damaged endothelial 
cells and the underlying mechanism involved in 






The HUVECs were provided by Nanchang 
University Medical School. The current study 
was approved by the Ethics Committee of 
Nanchang University (China). Trypsin and 3-(4, 
5-dimethylthiazal-z-yl)-2, 5-diphenylterazolium 
(MTT) were purchased from Sigma (St. Louis, 
USA), and Dulbecco’s Modified Eagle medium 
(DMEM) and fetal bovine serum (FBS) were 
purchased from GIBCO (Carlsbad, USA). 
Ligustrazine was obtained from the National 
Institute for the Control of Pharmaceutical and 
Biological Products (Beijing, China). The LDH, 
MDA, GSH, NOS, nitric oxide (NO), and SOD 
assay kits were from Nanjing Jiancheng 




The HUVECs were cultured in 25 cm2 plastic 
flasks at 37 °C in a humidified CO2 incubator (95 
% air and 5 % CO2). The complete medium for 
cell maintenance was 4.5 g/L glucose DMEM 
containing 10% FBS, L-glutamine, 100 IU/mL 
penicillin, and 100 IU/mL streptomycin. When 
cells were 80% confluent, they were subcultured 
using 0.25 % trypsin and 0.02 % EDTA, and the 
medium was changed every two days. Cells 
between passages 3 and 10 were used in the 
present study. 
 
Determination of H2O2 concentration in 
oxidative stress model (MTT assay) 
 
The concentration-dependent studies of 
HUVECs induced by H2O2 were conducted using 
MTT assay. HUVECs were counted and seeded 
into 96-well culture plates at a density of 
5×103 cells/well. The cells were washed twice 
with PBS after incubation with various H2O2 
concentrations (0, 50, 100, 200, and 400 µM) for 
8 h. For each well, the cells were then incubated 
with 100 μL MTT (final concentration of 
0.5 mg/mL) for 4 h. After MTT removal, the 
colored formazan was dissolved in 100 μL of 
DMSO. The absorption values were measured at 
490 nm using a Thermo Scientific Multiskan MK3 
Microplate Reader (Thermo Fisher, USA). The 
viability of HUVECs in each well was presented 
as percentage of control cells. Six independent 
replicates were performed for each group. 
 
Confocal laser scanning microscopy (CLSM) 
 
The HUVECs were cultured as described above 
and were stained with Hoechst 33258 for 30 min 
at 37 °C. Cell shape and nuclear morphology 
with apoptotic characteristics were observed 
immediately using Zeiss LSM 710 confocal laser 
scanning microscope (Carl Zeiss MicroImaging 
GmbH, Germany). 
 
Evaluation of ligustrazine cytotoxicity 
 
The effect of ligustrazine on HUVEC viability was 
evaluated via MTT assay in 96-well plates at a 
cell density of 5 × 103 cells per well. The cells 
were washed twice with PBS, after being pre-
treated with ligustrazine (10, 20, 40, 80, 160, and 
320 μmol/L) for 24 h. The MTT assay was done 
under the conditions described earlier. 
 
Evaluation of effect of ligustrazine on the 
viability of H2O2-induced HUVECs 
 
The cells were cultured as described above. The 
HUVECs were randomly divided into the control, 
H2O2, and five ligustrazine groups (5, 10, 20, 40, 
and 80 μmol/L + 100 µmol/L H2O2). Sub-
confluent cells were pre-treated with the medium 
containing various concentrations (5, 10, 20, 40, 
and 80 μmol/L) of ligustrazine for 24 h. 
Thereafter, a final 100 µmol/L H2O2 
concentration was added to the culture medium 
for 8 h, which was designated as the ligustrazine 
group. The control group was treated with the 
culture medium only, whereas the oxidative 
injury model of HUVECs established using H2O2 
was regarded as the H2O2 group. Subsequently, 
the effect of ligustrazine on the H2O2-induced 
HUVECs was measured via MTT assay. 
 
Evaluation of oxidative stress parameters 
 
The percentage of LDH release, NO production, 
SOD, GSH-Px, and NOS activities, and MDA 
concentration were determined using 
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commercially available assay kits (Jiancheng 
Bioengineering Research Institute, Nanjing, 
China). All procedures complied with the 
manufacturer's instructions. In addition, the 
percentage of LDH release was defined as the 
release of LDH in the supernatant/(release of 
LDH in the supernatant + release of LDH from 




Here, HUVECs were harvested, washed, and 
double-stained with an Annexin V–fluorescein 
isothiocyanate apoptosis detection kit (BD 
Biosciences, USA). The cells were incubated in 
the dark at 4 °C for 10 min to 15 min and 
analyzed using a BD FACS CaliburTM flow 
cytometry system (Becton Dickinson, USA). All 
tests were done in triplicate. 
 
Determination of the mitochondrial 
membrane potential (ΔΨm) 
 
Rhodamine 123, a cationic fluorescent dye 
whose mitochondrial fluorescence intensity 
decreases quantitatively with the dissipation of 
the mitochondrial membrane potential, was used 
to evaluate perturbations in mitochondrial 
membrane potential [10]. The HUVECs were 
cultured as described above and divided into 
different groups (control, H2O2, and ligustrazine 
groups). After 24 h treatment, cells were 
harvested and washed twice with cold PBS and 
then incubated in the dark with rhodamine 123 
(1 µmol/L) for 30 min at 37 °C. Fluorescence was 
measured using flow cytometry with an excitation 
wavelength of 485 nm. 
 
Detection of caspase activity 
 
The cells were cultured and treated as 
aforementioned. The fluorometric specific 
detection kits (KeyGEN, China) containing 
fluorescent substrates were used to analyze the 
activities of caspase 3, 8, and 9. The protocol for 
detecting caspase activity was conducted 
according to the manufacturer’s directions. 
Experiments were performed in triplicate. 
 
Quantitative real-time (qRT)-PCR analysis of 
mRNA expression 
 
The total RNA was extracted from cultured cells 
using Trizol reagent (Invitrogen, USA). The RNA 
concentrations were determined at 260 nm, and 
the samples were then stored in a freezer. First-
strand cDNA was synthesized from 1 μg of total 
RNA using PrimerScriptTM RT-PCR kit (TaKaRa 
Code: DRR041A) according to the 
manufacturer’s instructions. The expression 
levels of genes (β-actin, caspase-3, caspase-8, 
and caspase-9) in each sample were determined 
via qRT-PCR in the ABI 7900HT Real-Time PCR 
system (Applied Biosystems, USA). The 
florescence signals were detected with the ABI 
7900HT Version 2.3 sequence detection system 
(Applied Biosystems, USA). The PCR conditions 
were as follows: 95 °C for 30 s, followed by 40 
cycles at 95 °C for 5 s, and 60 °C for 1 min. The 
gene expression data were normalized to the 
endogenous control β-actin, and the relative 
mRNA expression was calculated using the 
comparative cycle threshold (∆Ct) method. ∆Ct is 
the difference between the Ct values of the 
target gene and β-actin. The primers used for 
qRT-PCR are listed in Table 1. 
 
Statistical analysis  
 
Statistical analysis was performed using the 
SPSS 17.0 package. The values are presented 
as mean ± standard deviation (SD, n ≥ 3). One-
way ANOVA and Student’s t-test were 
conducted to determine statistical significance. 
Differences between groups were considered 




Concentration-dependent survival rate of 
H2O2-induced HUVECs 
 
Studies on the concentration-dependent survival 
rate of H2O2-induced HUVECs were performed 
in the present study. As shown in Figure 1, the 
survival rates gradually decreased with the 
increase in H2O2 concentration. When H2O2  
 
Table 1: Primer sequences used for qRT-PCR 
 






β-actin AGTTGCGTTACACCCTTTCTTG CACCTTCACCGTTCCAGTTTT 152 
Caspase-3 TGTGAGGCGGTTGTGGAAGAGT AATGGGGGAAGAGGCAGGTGCA 182 
Caspase-8 TGTCCTTCCTGAGGGAGCTGCT TGAGCCCTGCCTGGTGTCTGAA 115 
Caspase-9 TGGAGGATTTGGTGATGTCGAGCA ATCTGGCTCGGGGTTACTGCCA 97 
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concentration was higher than 100 µmol/L, the 
survival rate decreased by 11.45 ± 2.62 % (p < 
0.05, compared with control), suggesting that 
100 µmol/L of H2O2 can induce cell injury. 
Previous studies indicate H2O2 concentrations in 
the oxidative stress model system ranging from 






















concentration (μmol/L)  
Figure 1: Survival rates of HUVECs induced by H2O2. 
Values are mean ± S.D. (n ≥ 4). Values with different 
letters are significantly difference in a concentration-
dependent manner (p < 0.05).  
 
Apoptosis of HUVECs detected via Hoechst 
33258 fluorescence staining 
 
The CLSM results indicate that normal cells 
display weak fluorescence, whereas apoptotic 
cells show increasing bright fluorescence and 
typical apoptotic bodies. As shown in Figure 2, 
the chromatin in nucleus seemed to be 
condensed and marginalized in the H2O2 group, 




A   B 
Figure 2: The micrograph of HUVECs in the control 
group (A) and H2O2 group (B) by CLSM. The results 
show that H2O2 can result in HUVECs apoptosis. 
 
Cytotoxicity of ligustrazine on HUVECs 
 
The effect of ligustrazine on the viability of 
normal HUVECs was concentration dependent 
(Figure 3). When the concentration was more 
than 160 µmol/L, the survival rate was 81.29 
±3.18 %, which is significantly less than that of 
the control group (p < 0.05). However, 
ligustrazine at concentrations ≤ 80 µmol/L had 
negligible inhibitory effect on HUVECs survival. 
Therefore, ligustrazine concentrations less than 





















Figure 3: The effect of ligustrazine on the survival 
rates of HUVECs.  
 
Protective effect of ligustrazine on the 
viability of H2O2-induced HUVECs 
 
The protective effects of ligustrazine on the 
viability of H2O2-induced HUVECs were 
evaluated via MTT assay. As shown in Figure 4, 
the survival rate of HUVECs was about 
64%±3.8% after exposure to 100 µmol/L of H2O2 
for 8 h. However, pre-incubation of HUVECs with 
ligustrazine (5, 10, 20, 40, and 80 µmol/L) for 
24 h can increase the viability of H2O2-induced 
HUVECs in a dose-dependent manner (p < 
0.05), and the survival rates were 67.06 ± 3.95, 
71.75 ±1.24, 74.44 ± 3.80, 82.00 ±1.20, and 
86.91 ± 2.86 %, respectively. These rates 
suggest that ligustrazine can protect HUVECs 






















Figure 4: The protective effects of ligustrazine on 
HUVECs against oxidative injury. 
Pentagram (☆) indicates statistically significant 
differences between the H2O2 group and control 
group.  
 
Influence of ligustrazine on oxidative stress 
indicators of H2O2-induced injury 
 
LDH release, MDA and NO concentrations, and 
SOD, GSH-Px, and NOS activities were 
investigated to further confirm the protective 
effects of ligustrazine on H2O2-induced injury in 
HUVECs. As shown in Table 2, LDH release was 
Huang et al 
Trop J Pharm Res, December 2013;12 (6): 
 
953 
16.28 ± 1.71 % in the control group, and a 
dramatic increase (34.89 ± 0.98 %) was 
observed after exposure to 100 µmol/L of H2O2 
for 8 h. However, pre-treatment with the different 
concentrations of ligustrazine (> 5 µmol/L) for 
24 h attenuated the H2O2-induced increase in 
LDH release (p < 0.05, Table 2). 
 
The MDA concentration in the control group was 
23.78 ± 2.15 nmol/mg of protein, whereas that in 
HUVECs treated with 100 µmol/L of H2O2 for 8 h 
significantly increased (45.70 ± 3.14 nmol/mg of 
protein) (p < 0.05, Table 2). Meanwhile, the MDA 
concentrations in cells pre-treated with various 
concentrations of ligustrazine (5, 10, 20, 40, and 
80 µmol/L) for 24 h decreased. 
 
As shown in Table 2, the NO level and NOS 
activity in HUVECs exposed to 100 µmol/L of 
H2O2 for 8 h (p < 0.05, with 27.44 ± 4.34 µmol/L 
and 1.95 ± 0.20 U/mg of protein, respectively) 
significantly decreased compared with those of 
the control group (73.30 ± 7.00 µmol/L and 4.18 
± 0.77 U/mg of protein, respectively). However, 
24 h pre-treatment with ligustrazine (5, 10, 20, 
40, and 80 µmol/L) could trigger a distinct, dose-
dependent increase in these indicators. 
 
Treating HUVECs with 100 µmol/L of H2O2 
caused a significant decrease in SOD and GSH-
Px activities (45.16 ± 3.25 and 77.81 ± 
4.29 U/mg of protein, respectively) compared 
with that in the control group (129.76 ± 15.52 
and 160.13 ± 3.73 U/mg of protein, respectively) 
(p < 0.05, Table 2). However, pre-incubation with 
ligustrazine (5, 10, 20, 40, and 80 µmol/L) for 
24 h attenuated the changes in SOD and GSH-
Px activities. 
 
All of these results suggest that ligustrazine can 
be an anti-oxidative agent protecting HUVECs 
against oxidative stress. 
 
Effect of ligustrazine on apoptosis 
 
The percentages of cells that stepped into early 
apoptosis and late apoptosis or necrosis were 
52.7% and 0.6%, respectively, in the H2O2 
group, and 38.2% and 1.3%, respectively, in the 
ligustrazine group (80 µmol/L) (Figure 5). These 
results suggest that ligustrazine has a protective 
effect on HUVECs against oxidative damage, 
which is particularly important in maintaining 
normal physiological function and preventing the 
formation of atherosclerotic plaques. 
















Control 16.28±1.71 23.78±2.15 4.18±0.77 73.30±7.00 129.76±15.52 160.13±3.73 
H2O2 34.89±0.89*a 45.70±3.14*a 1.95±0.20*a 27.44±4.34*a 45.16±3.25*a 77.81±4.29*a 
5 µM of 
Ligustrazine  
33.68±0.81a 42.98±2.96ab 2.15±0.50a 32.20±4.13ab 57.98±9.53a 81.75±1.08ab 
10 µM of 
Ligustrazine  
32.78±1.49b 40.23±2.10abc 2.23±0.29ab 46.05±8.47ab 60.64±8.85b 83.37±2.15bc 
210 µM of 
Ligustrazine 
29.86±0.44c 38.66±4.91bcd 2.60±0.35bc 53.60±8.02ab 74.00±3.63b 90.44±4.06cd 
40 µM of 
Ligustrazine 
27.42±0.83d 36.52±2.68cd 2.94±0.81cd 68.07±3.30b 82.51±1.68c 96.96±2.43d 
80 µM of 
Ligustrazine 
25.90±0.50d 34.41±3.65d 3.01±0.33d 69.61±11.42b 107.28±5.18c 110.39±9.56e 
Note: Asterik (*) indicates statistically significant differences between the control and H2O2 group. a, b, c, d, e indicate 
statistically significant differences between the H2O2 group and ligustrazine group.  
 
      
A                                          B             C 
 
Figure 5: The flow cytometry of HUVECs apoptotic cells after treatment with the H2O2 and ligustrazine. Quadrant 
analysis of fluorescence intensity of gated cells in Annexin V-FITC and PI channels was from 16,000 events. A = 
control; B = H2O2 group; C = ligustrazine group (80 µmol/L). 
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Effect of ligustrazine on t mitochondrial 
membrane potential (ΔΨm) 
 
The changes in mitochondrial membrane 
potential reflect the initial cell apoptotic 
phenomenon. Here, ΔΨm was measured using 
flow cytometry. A substantial decrease in ΔΨm 
was observed in HUVECs upon exposure to 
H2O2. However, after pre-treatment with different 
concentrations of ligustrazine (20 and 
80 μmol/L), ΔΨm increased to a value higher 
than that in the H2O2 group (Figure 6). These 
data indicate that ligustrazine could protect 
HUVECs against oxidative stress via 
mitochondrial induction pathways. 
 
 
Figure 6: Effect of ligustrazine on mitochondrial membrane potential in HUVECs. 
The Δψm depolarization was detected using flow cytometry with Rh123 staining. A = control group; B = H2O2 









c as p as e3
c as p as e8  
c as p as e9  























Figure 7: Effect of ligustrazine on the activities of caspase 3, 8 and 9 in HUVECs. 
Asterisks (*) indicate statistically significant differences between the control, H2O2 group, and ligustrazine group 
(p < 0.05). Values with different letters indicate statistically significant differences between the H2O2 group and 
ligustrazine group (p < 0.05). 
 
Effect of ligustrazine on caspase 3, 8, and 9 
activities 
 
Caspase 3, 8, and 9 activities are associated 
with specific intracellular polypeptide degradation 
during apoptosis. Caspase 8 and 9 are initiator 
caspases, and caspase 3 is considered as the 
main executor of apoptosis. The results in Figure 
7 indicate that caspase 3, 8, and 9 activities are 
lower in the ligustrazine group than those in the 
H2O2 group, suggesting that ligustrazine can 
protect HUVECs against oxidative stress and, 
hence, apoptosis. 
Effect of ligustrazine on mRNA expression of 
caspase 3, 8, and 9 
 
The mRNA expression levels of caspase 3, 8, 
and 9 were measured via qRT-PCR. The results 
reveal that the mRNA levels of caspase 3, 8, and 
9 are significantly up-regulated in the H2O2 group 
compared with those in the control group (p < 
0.05). Pre-treatment with ligustrazine in 
endothelial cells led to a decrease in the mRNA 
expression levels of caspase 3, 8, and 9 that 
coincide with the enzyme changes (Figure 8), 
suggesting that the anti-apoptotic mechanism of 
ligustrazine may be caspase dependent.
 
 
A B C D 
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Figure 8: Effect of ligustrazine on the mRNA expression of caspase 3, 8, 9 in HUVECs. C = control group; H = 
H2O2 group; Lr = Low ligustrazine concentration (20 µmol/L); Hr = High ligustrazine concentration (80 µmol/L). 
Asterisk (*) indicates statistically significant differences between control, H2O2 group, and ligustrazine group (p < 
0.05). Values with different letters indicate statistically significant differences between H2O2 and ligustrazine 




A variety of factors, such as inflammatory 
cytokines, reactive oxygen species (ROS), and 
lipid oxidation enzymes, could result in vascular 
endothelial cell damage, of which the damage 
caused by ROS is the most crucial [12]. Oxygen 
free radicals, the main oxidizing substances, 
participate in the body's normal physiological 
activity. Oxyradicals are closely related to the 
body's metabolism and signal transduction and 
play an important role in cell physiological 
function. Normally, a small amount of oxyradicals 
are by-products of cellular metabolism. However, 
under certain conditions, large amounts of 
oxyradicals are generated from the intracellular 
system, which may cause irreversible oxidative 
damages. H2O2 has been suggested as inducer 
of apoptosis in several types of cells [13]. In the 
current study, the oxidative injury model was 
established with H2O2 as inducer of HUVEC 
apoptosis. As reported previously, the viability 
and proliferation of HUVECs significantly 
decreased after H2O2 exposure. Morphological 
analysis showed similar results, with the 
chromatin in nucleus appearing to be condensed 
and marginalized in the H2O2 group upon 
observation via CLSM. 
 
ROS affects lipids and leads to lipid peroxidation, 
which thus produces MDA. MDA might combine 
with proteins, amino acids, and other cellular 
components and hence change the structure of 
phospholipids. Moreover, LDH is released into 
the culture medium when cell trauma occurred 
[7]. In the current study, ligustrazine significantly 
increased SOD and GSH-Px activities but 
decreased LDH release and MDA content. Thus, 
after pre-treatment with ligustrazine, HUVECs 
have the ability to resist damage from oxygen 
free radicals, reduce lipid peroxidation, and 
maintain biomembrane integrity. Moreover, 
according to the flow cytometry analysis of 
apoptosis, ligustrazine ameliorates apoptosis 
induced by oxidative stress. This observation is 
consistent with a previous study, which showed 
that ligustrazine can ameliorate apoptosis [14]. 
The current study demonstrates that ligustrazine 
is effective in protecting cells against oxidative 
damage induced by H2O2, which is particularly 
important in preventing the formation of 
atherosclerotic plaques. 
 
NOS, the most important active enzyme in 
maintaining the physiological function of 
endothelial cells, has the ability to remove free 
radicals in vivo. Moreover, NOS is an enzyme 
responsible for the formation of NO [15], which is 
responsible for vasodilation, blood pressure 
regulation, cardiac contractility, and the 
mediation of immunity during bacterial infections 
and inflammation [16]. Compared with those of 
the control group, the NO and NOS expression 
levels of the H2O2 group decreased. However, 
the NO and NOS expression levels increased 
after pre-treatment with ligustrazine. The results 
suggest that the effect of ligustrazine on a 
meliorating H2O2-induced apoptosis is partly 
through the regulation of the NO pathway. 
 
Massive vascular endothelial cell apoptosis 
occurs in atherosclerotic plaque. Moreover, 
excessive HUVEC apoptosis is involved in the 
initial stage of AS [17]. Hence, the prevention 
and control of AS by inhibiting the excessive 
apoptosis of vascular endothelial cells is greatly 
important. 
 
Apoptosis may be mediated by two main signal 
transduction pathways, the death receptor 
pathway and mitochondrial induction pathways 
[18]. The triggering mechanism of the caspase 
cascade in apoptosis was explored in the current 
Huang et al 
Trop J Pharm Res, December 2013;12 (6): 
 
956 
study to further confirm the protection against 
H2O2-induced apoptosis by ligustrazine. Recent 
evidence suggests that the opening of the 
mitochondrial permeability transition (MPT) pore 
is a critical event in the process, which leads to 
apoptosis under oxidative stress. The opening of 
the MPT pore can cause the dissipation of the 
inner mitochondrial transmembrane potential 
(ΔΨm), culminating in the disruption of outer 
membrane integrity, which then leads to the 
release of intermembrane proteins from the 
mitochondrion [19]. Once the pro-apoptotic 
factors move from the mitochondria into the 
cytosol, these apoptogenic proteins activate 
caspase proteases, amplifying apoptosis. 
Caspases are family members of cysteine 
proteases that mediate cell death and are critical 
regulators of apoptosis[20]. Studies have 
indicated that at least 11 kinds of caspase exist. 
Caspases 8 and 9 participate in the beginning of 
apoptosis, whereas caspase 3 is involved in the 
implementation of apoptosis. Our results show 
that the addition of ligustrazine attenuated the 
decrease in ΔΨm and the up-regulation of 
caspase 3, 8, and 9 mRNA and activity, 
suggesting that the anti-apoptotic mechanism of 
ligustrazine against oxidative stress is a 
caspase-dependent pathway involved in 




In summary, ligustrazine can protect HUVECs 
against H2O2-induced injury by regulating the 
indicators related to oxidative stress, enhancing 
anti-oxidant enzyme activity, and suppressing 
the overexpression of caspases 3, 8, and 9. The 
protective mechanism of ligustrazine on H2O2-
induced injury in HUVECs may be a caspase-
dependent, anti-apoptotic mechanism involved in 
mitochondrial induction pathways. The results of 
the present study provide important information 
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